<p>Cognitive dysfunction is common non-motor symptom (NMS) in Parkinson's disease (PD), which affects the patients' quality of life and increases the burden of caregivers. Cognitive dysfunction in PD can be mild cognitive impairment (MCI) or dementia. MCI presents in the early stage of PD and the incidence rate is increasing with the disease progression. In some cases it can advance to dementia. The diagnosis of MCI in PD includes inclusion criteria, exclusion criteria and damage level evaluation. Non-pharmacological therapy, such as exercise and cognitive behavior therapy (CBT) can improve the symptoms of MCI in PD, while the pharmacological treatment remains to be further studied.</p><p> </p><p><strong>DOI: </strong>10.3969/j.iss...
People with Parkinson’s disease (PD) and their care partners frequently report cognitive decline as ...
Mild cognitive impairment has gained recognition as a construct and a potential prodromal stage to d...
Cognitive impairment is common in Parkinson's disease (PD), and many patients will eventually develo...
<p>Cognitive dysfunction is one of the common non-motor symptoms (NMS) in Parkinson's disease (PD),...
A substantial percentage of patients with newly diagnosed Parkinson's disease without dementia are r...
Cognitive dysfunction is a common and significant non-motor symptom of Parkinson’sdisease (PD). PD m...
Parkinson’s disease (PD) is the second most common progressive neurodegenerative disorder mainly in ...
BACKGROUND/AIMS: The frequency of mild cognitive impairment (MCI) in Parkinson's disease (PD) range...
Mild cognitive impairment is common in nondemented Parkinson's disease (PD) patients and may be a ha...
Mild cognitive impairment associated with Parkinson's disease (PD) is a risk factor for the developm...
Approximately 30% of Parkinson's disease (PD) patients show impaired cognitive performance, which is...
The concept of Mild Cognitive Impairment is a newly defined entity within the context of Parkinson’s...
Abstract Background Mild cognitive impairment in Parkinson’s disease (PD-MCI) is a common clinical c...
Parkinson’s disease (PD) is a common, disabling, neurodegenerative disorder. In addition to classica...
Parkinson's disease (PD) is a common neurodegenerative disorder, characterized by motor and nonmotor...
People with Parkinson’s disease (PD) and their care partners frequently report cognitive decline as ...
Mild cognitive impairment has gained recognition as a construct and a potential prodromal stage to d...
Cognitive impairment is common in Parkinson's disease (PD), and many patients will eventually develo...
<p>Cognitive dysfunction is one of the common non-motor symptoms (NMS) in Parkinson's disease (PD),...
A substantial percentage of patients with newly diagnosed Parkinson's disease without dementia are r...
Cognitive dysfunction is a common and significant non-motor symptom of Parkinson’sdisease (PD). PD m...
Parkinson’s disease (PD) is the second most common progressive neurodegenerative disorder mainly in ...
BACKGROUND/AIMS: The frequency of mild cognitive impairment (MCI) in Parkinson's disease (PD) range...
Mild cognitive impairment is common in nondemented Parkinson's disease (PD) patients and may be a ha...
Mild cognitive impairment associated with Parkinson's disease (PD) is a risk factor for the developm...
Approximately 30% of Parkinson's disease (PD) patients show impaired cognitive performance, which is...
The concept of Mild Cognitive Impairment is a newly defined entity within the context of Parkinson’s...
Abstract Background Mild cognitive impairment in Parkinson’s disease (PD-MCI) is a common clinical c...
Parkinson’s disease (PD) is a common, disabling, neurodegenerative disorder. In addition to classica...
Parkinson's disease (PD) is a common neurodegenerative disorder, characterized by motor and nonmotor...
People with Parkinson’s disease (PD) and their care partners frequently report cognitive decline as ...
Mild cognitive impairment has gained recognition as a construct and a potential prodromal stage to d...
Cognitive impairment is common in Parkinson's disease (PD), and many patients will eventually develo...